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Abstract
Aminopeptidase N (APN/CD13) and neutral endopeptidase (NEP/CD10) are enzymes present in human sperm 
cells and involved in regulation of sperm motility of noncapacitated spermatozoa.  We investigated the involvement of 
APN/CD13 and NEP/CD10 in motility and in kinematic parameters of human capacitated spermatozoa.  Sperm cells 
isolated by a discontinuous Percoll gradient (40%–80%) followed up by swim-up techniques were incubated with the 
APN/CD13-specific inhibitor, leuhistin (100 µmol L-1), and the NEP/CD10-specific inhibitor, thiorphan (1 µmol L-1). 
The complete inhibition of both APN/CD13 and NEP/CD10 improved sperm motility.  Spermatozoa incubated with 
the APN/CD13-specific inhibitor leuhistin showed asymmetrical trajectories, whereas sperm trajectories were more 
regular after treatment with the NEP/CD10-specific inhibitor thiorphan.  In conclusion, APN/CD13 and NEP/CD10 
modulate the motility of capacitated spermatozoa, although each of the enzymes seems to participate in the control 
of different aspects of sperm motility.  Therefore, both inhibitors may be useful for sperm activation at different 
functional stages of spermatozoa. 
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1    Introduction
Sperm motility appears to be essential for natural 
reproduction and is an important feature and currently 
the most reliable predictor of male factor infertility [1, 2]. 
Activation of sperm motility occurs upon release from the 
male and is modified during the transport of spermatozoa 
through the female reproductive tract. When deposited 
inside female reproductive tract, sperm cells develop a 
progressive motility which must develop to hyperactive 
motility when they arrive to the oviduct [2, 3]. 
Aminopeptidase N (APN/CD13) and neutral en-
dopeptidase 24:11 (NEP/CD10) are surface membrane 
multifunctional enzymes and both are present in human 
sperm cells [4, 5]. Therefore, the aim of this study was 
to investigate the involvement of APN/CD13 and NEP/
CD10 in motility of human capacitated spermatozoa.
2    Materials and methods
2. 1  Reagents
Leuhistin was obtained from Calbiochem (La Jolla, 
CA, USA) and thiorphan was purchased from Sigma-
Aldrich (St. Louis, MO, USA). 
2. 2  Methods
Human semen was obtained from healthy donors 
by masturbation after 2–3 days of abstinence; the do-
nors were normozoospermic according to World Health 
Organization standards [6].  Ethical approval was ob-
tained from the Ethics Committee of the University of 
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the Basque Country and from the Cruces Hospital Ethics 
Committee.  Informed consent was obtained from all do-
nors.  Samples were ejaculated into sterile containers and 
allowed to liquefy at 37 ºC for 30 min before processing. 
Spermatozoa were isolated using a discontinuous 
Percoll gradient (40%–80%) followed by a swim-up 
procedure and they were capacitated for 5 h at 37 ºC in 
5% CO2 in G-IVF (Vitrolife, Göteborg, Sweden).  Iso-
lated sperm cells were resuspended to ∼50 × 106 cells 
per mL and incubated with the APN-specific inhibitor 
leuhistin (100 µmol L-1), the NEP-specific inhibitor 
thiorphan (1 µmol L-1) or the corresponding solvent 
(control aliquots).  At these concentrations, both en-
zymes were completely inhibited [4].  The percentage 
of motile sperm and kinematic parameters were meas-
ured using an SCA (Sperm Class Analyzer) system fol-
lowing the WHO recommendations [6]: grade A sperm 
(rapidly progressive), grade B (slow/sluggish progres-
sive), grade C (nonprogressive motility) and grade D 
(immobile), progressive motility (grade A+B sperm), 
curvilinear velocity (VCL), straight-linear velocity 
(VSL), average velocity (VAP), linearity index (LIN = 
VSL/VCL), straightness index (STR = VSL/VAP), oscilla-
tion index (WOB = VAP/VCL), amplitude of lateral head 
displacement (ALH) and beat-cross frequency (BCF). 
The Mann–Whitney nonparametric test was used to 
compare normalized data ([treatment−control]/control × 
100) between different time periods of incubation. 
3    Results and discussion
The inhibition of APN/CD13 and NEP/CD10 by 
Figure 1.  Effect of APN/CD13 inhibition (A) and NEP/CD10 inhibition (B) on sperm motility at 0 (2 min), 0.5, 1 and 3 hours of incu-
bation. Percentage of A, B, C, D and progressive (A+B) grade sperm after the addition of leuhistin (100 µmol L-1). Normalized data are 
expressed as mean + SEM.  (*P < 0.05, **P < 0.01,  compared with control as 0%; n = 7).
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Figure 2.  Effect of APN/CD13 inhibition on kinematic parameters at 0 (2 min), 0.5, 1 and 3 h of incubation.  (A) Velocity values: VCL, VSL 
and VAP (µm/s); (B) ratios of the velocities: LIN, STR and WOB (%); (C) amplitude of lateral head of displacement: AHL(µm); (D) BCF (Hz) 
during the time period on leuhistin treatment.  Normalized data are expressed as mean + SEM (*P < 0.05, **P < 0.01 vs. control as 0%; n = 7).
Abbreviations: VCL, curvilinear velocity; VSL, straight-linear velocity; VAP, average velocity; LIN = VSL/VCL, linearity index; STR = VSL/
VAP, straightness index; WOB = VAP/VCL, oscillation index; ALH, amplitude of lateral head displacement and BCF: beat-cross frequency. 
Figure 3.  Effect of NEP/CD10 inhibition on kinematic parameters at 0 (2 min), 0.5, 1 and 3 h of incubation.  (A) Velocity values: VCL, 
VSL and VAP (µm s-1); (B) ratios of the velocities: LIN, STR and WOB (%); (C) AHL (µm); (D) BCF (Hz) during the time period on 
thiorphan treatment. Normalized data are expressed as mean + SEM (*P < 0.05, compared with control as 0%; n = 5). Abbreviations: 
VCL, curvilinear velocity; VSL, straight-linear velocity; VAP, average velocity; LIN = VSL/VCL, linearity index; STR = VSL/VAP, straight-
ness index; WOB = VAP/VCL, oscillation index; ALH, amplitude of lateral head displacement and BCF: beat-cross frequency. 
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leuhistin and tiorphan, respectively, improved sperm 
motility (Figures 1A and B), but spermatozoa showed 
distinctly different trajectories after leuhistin and thior-
phan incubation.  Kinematic parameters define sperm 
trajectories; they should be useful to establish the dif-
ference between progressive and hyperactive motility 
[7–9].  After leuhistin treatment, sperm cells showed 
more asymmetric trajectories characteristic of hyperac-
tivation [8, 10], because the inhibitor increased VCL, 
ALH and BFC after incubation for 3 h (Figures 2A, C 
and D).  High values of these parameters are important, 
because only hyperactivated sperm can leave the fallo-
pian tube isthmus and penetrate the oocyte zona pellucida 
[11].  On the other hand, after thiorphan incubation, 
sperm cells showed more regular trajectories than those 
in the control aliquots characteristic of progressive mo-
tility, because thiorphan increased all velocity values 
(Figure 3A), linearity indices (Figure 3B) and the BCF 
(Figure 3D) of sperm cells, whereas AHL remained un-
altered (Figure 3C).  Only spermatozoa with regular and 
good progressive motility are able to swim through the 
female reproductive tract [7].  Our results suggest that 
APN/CD13 and NEP/CD10 control different aspects 
of sperm motility and that both inhibitors may be use-
ful for sperm activation at different functional stages of 
spermatozoa. 
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